(Q39899613)

English

Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors

scientific article

Statements

Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors (English)
Douglas Saffran
Stephen Kaufman
Brian Belmontes
James B Rottman
Richard Kendall
Robert Radinsky
Anthony Polverino

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit